Hydrochloric Acid

Hydrochloric Acid

SCHEMBL193045

CCCCc1[nH]cc[n+]1C.[Cl-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.33
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.31
CASP2 P42575 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HSPD1 P10809 1/20 0.31
RAD52 P43351 1/20 0.31
HSPE1 P61604 1/20 0.31
GPR84 Q9NQS5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2831078 0.98 HRH3 (0.32) HRH3MEN1MAPTMAPK1CASP2
Hydrochloric Acid SCHEMBL1782212 0.98 HRH3 (0.32) HRH3MEN1MAPTMAPK1CASP2
SCHEMBL107551 0.98 HRH3 (0.34) HRH3GPR84
Fluoride Ion SCHEMBL5046809 0.96 HRH3 (0.33) HRH3GPR84
Bromide SCHEMBL193081 0.96 HRH3 (0.33) HRH3MEN1MAPTMAPK1KMT2A
Iodide SCHEMBL247931 0.96 HRH3 (0.33) HRH3SMN1; SMN2GPR84
Water SCHEMBL1176980 0.96 HRH3 (0.33) HRH3GPR84
SCHEMBL8003081 0.96 HRH3 (0.33) HRH3GPR84
Hydrochloric Acid SCHEMBL2834153 0.94 KCNH2 (0.36) HRH3MEN1MAPTMAPK1CASP2
Bromide SCHEMBL15532008 0.94 HRH3 (0.32) HRH3MEN1MAPTMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 875 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746714-A1 ANTIMICROBIAL COMPOSITIONS INCLUDING COPPER(I) SALTS AND ADDITIVES Corning Incorporated (US) 2026-05-27 EP claimed
EP-4735622-A1 PROTECTING FULLY FUNCTIONAL NUCLEOTIDES FROM DEGRADATION Illumina, Inc. (US) 2026-05-06 EP claimed
EP-4709435-A1 THERAPEUTIC COMPOSITION KING'S COLLEGE LONDON (GB) 2026-03-18 EP claimed
EP-4709788-A1 EXTRUDABLE FIBER COMPOSITE MATERIAL AND ITS USE AND PRODUCTION No Plastic Trading AG (CH) 2026-03-18 EP claimed
EP-4665819-A1 A WASTE CONVERSION METHOD Cyclion Holdings Pty Ltd (AU) 2025-12-24 EP claimed
WO-2025137293-A2 ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY AROMATIC COMPOUNDS Roche Sequencing Solutions, Inc. (US) 2025-06-26 WO claimed
EP-4569006-A1 SOLVENT SYSTEMS AND METHODS FOR PROCESSING CHITIN Neptune Nanotechnologies Inc. (CA) 2025-06-18 EP claimed
EP-4551102-A1 AN ELECTRODE ARRAY FOR MEASURING THE PH OF ANIMAL TISSUES, A PROBE COMPRISING SUCH AN ARRAY, AND AN ASSEMBLY COMPRISING SAID PROBE Quantum Innovations Spolka Z Ograniczona Odpowiedzialnoscia (PL) 2025-05-14 EP claimed
WO-2025019153-A1 ANTIMICROBIAL COMPOSITIONS INCLUDING COPPER(I) SALTS AND ADDITIVES CORNING INCORPORATED (US) 2025-01-23 WO claimed
WO-2025003459-A1 PROTECTING FULLY FUNCTIONAL NUCLEOTIDES FROM DEGRADATION ILLUMINA, INC. (US) 2025-01-02 WO claimed
US-20090259032-A1 METHOD OF PRODUCING CELLULOSE CARBAMATE BLOWN FILM AND USE OF THE SAME FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2009-10-15 US claimed
US-20090258227-A1 METHOD OF PRODUCING CELLULOSE CARBAMATE FIBRE AND USE OF THE SAME FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2009-10-15 US claimed
WO-2009102307-A1 PRODUCTION OF CELLULOSE ESTERS IN THE PRESENCE OF A COSOLVENT EASTMAN CHEMICAL COMPANY (US) 2009-08-20 WO claimed
WO-2009102419-A2 ALUMINUM RECOVERY PROCESS THE UNIVERSITY OF ALABAMA (US) 2009-08-20 WO claimed
WO-2009080522-A1 SYNTHESIS OF AU, PD, PT OR AG NANO- OR MICROCRYSTALS VIA REDUCTION OF METAL SALTS BY CELLULOSE IN THE IONIC LIQUID 1-BUTYL-3-METHYL IMIDAZOLIUM CHLORIDE UNIVERSITÄT POTSDAM (DE) 2009-07-02 WO claimed
WO-2008128306-A1 METHOD FOR THE PREPARATION OF REACTIVE [18] F FLUORIDE TRASIS S.A. (BE) 2008-10-30 WO claimed
WO-2007032022-A2 CONSOLIDATION OF NON-WOVEN TEXTILE FIBRES PREETI LODHA (IN) 2007-03-22 WO claimed
US-20050054694-A1 Catalyst comprising indium salt and organic ionic liquid and process for friedel-crafts reactions QUEEN'S UNIVERSITY OF BELFAST, THE (GB) 2005-03-10 US claimed
EP-1432512-A1 CATALYST COMPRISING INDIUM SALT AND ORGANIC IONIC LIQUID AND PROCESS FOR FRIEDEL-CRAFTS REACTIONS The Queen's University of Belfast (GB) 2004-06-30 EP claimed
WO-2003028883-A1 CATALYST COMPRISING INDIUM SALT AND ORGANIC IONIC LIQUID AND PROCESS FOR FRIEDEL-CRAFTS REACTIONS THE QUEEN'S UNIVERSITY OF BELFAST (GB) 2003-04-10 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054694-A1 Catalyst comprising indium salt and organic ionic liquid and process for friedel-crafts reactions CEL, KAT5, LEF1 HRH3 1167/4885MEN1 3418/4885MAPT 3167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.